Menstrual and Reproductive Characteristics of Patients with Primary Sjogren’s Syndrome: A 7-year Single-center Retrospective Study

Abstract

Objective

Primary Sjogren’s syndrome (pSS) is a systemic autoimmune disease that mainly affects the exocrine gland, especially in women. Currently, the results of studies on the menstruation or fertility of pSS patients remain controversial. This study aimed to examine the menstrual and reproductive characteristics of pSS patients.

Methods

Clinical data of 449 pSS patients who were admitted to Tongji Hospital in Hubei, China, from January 2015 to November 2021 were obtained and their menstrual and reproductive information analyzed. In addition, the clinical features of pSS patients with premenopausal or postmenopausal onset were compared.

Results

The spontaneous abortion rate of pSS patients was not higher than the reported rate of the general population and that the age of menarche, menstrual cycle, and menstrual period of pSS patients did not significantly differ from those reported in the general population; however, early menopause seemed to be more common in pSS patients. Skin involvement (27.96% vs. 15.00%, P=0.005) and hyperglobulinemia (10.64% vs. 4.16%, P=0.033) were more common in patients with premenopausal pSS onset, but patients with postmenopausal onset had a significantly greater incidence of interstitial lung disease (32.50% vs. 17.02%, P=0.0004). Also, erythropenia (47.00% vs. 31.25%, P=0.002), hypoalbuminemia (19.49% vs. 8.22%, P=0.0009), and prevalence of high hypersensitive C-reactive protein levels (21.67% vs. 10.94%, P=0.005) were more common in pSS patients with postmenopausal onset. Notably, the rate of abnormal pregnancy was significantly greater in patients with premenopausal onset (9.72% vs. 2.50%, P=0.011).

Conclusion

Patients with pSS onset before or after menopause may have different risks in pulmonary involvement and laboratory manifestations.

References

[1] ShiboskiCH, ShiboskiSC, SerorR, et al.. 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjogren’s Syndrome: A Consensus and Data-Driven Methodology Involving Three International Patient Cohorts. Arthritis Rheumatol, 2017, 69(1): 35-45

[2] Brito-ZerónP, BaldiniC, BootsmaH, et al.. Sjögren syndrome. Nat Rev Dis Primers, 2016, 2: 16047

[3] FoxRI. Sjögren’s syndrome. Lancet, 2005, 366(9482): 321-331

[4] De CarolisS, SalviS, BottaA, et al.. The impact of primary Sjogren’s syndrome on pregnancy outcome: our series and review of the literature. Autoimmun Rev, 2014, 13(2): 103-107

[5] BallesterC, GrobostV, RoblotP, et al.. Pregnancy and primary Sjögren’s syndrome: management and outcomes in a multicentre retrospective study of 54 pregnancies. Scand J Rheumatol, 2017, 46(1): 56-63

[6] HusseinSZ, JacobssonLT, LindquistPG, et al.. Pregnancy and fetal outcome in women with primary Sjogren’s syndrome compared with women in the general population: a nested case-control study. Rheumatology (Oxford), 2011, 50(9): 1612-1617

[7] ElliottB, SpenceAR, Czuzoj-ShulmanN, et al.. Effect of Sjögren’s syndrome on maternal and neonatal outcomes of pregnancy. J Perinat Med, 2019, 47(6): 637-642

[8] McCoySS, SampeneE, BaerAN. Association of Sjögren’s Syndrome With Reduced Lifetime Sex Hormone Exposure: A Case-Control Study. Arthritis Care Res (Hoboken), 2020, 72(9): 1315-1322

[9] LuMC, HsiehMC, KooM, et al.. Risk of Sjögren’s syndrome in Taiwanese female adults with irregular menstrual cycles: a population-based case-control study. Rheumatol Int, 2016, 36(1): 155-160

[10] UpalaS, YongWC, SanguankeoA. Association between primary Sjögren’s syndrome and pregnancy complications: a systematic review and meta-analysis. Clin Rheumatol, 2016, 35(8): 1949-1955

[11] HagaHJ, GjesdalCG, IrgensLM, et al.. Reproduction and gynaecological manifestations in women with primary Sjögren’s syndrome: a case-control study. Scand J Rheumatol, 2005, 34(1): 45-48

[12] PasotoSG, AugustoKL, AlvarengaJC, et al.. Cortical bone density and thickness alterations by high-resolution peripheral quantitative computed tomography: association with vertebral fractures in primary Sjögren’s syndrome. Rheumatology (Oxford), 2016, 55(12): 2200-2211

[13] BalariniGM, ZandonadeE, TanureL, et al.. Serum calprotectin is a biomarker of carotid atherosclerosis in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol, 2016, 34(6): 1006-1012

[14] ZhengD, LiC, WuT, et al.. Factors associated with spontaneous abortion: a cross-sectional study of Chinese populations. Reprod Health, 2017, 14(1): 33

[15] HuCY, YangXJ, HuaXG, et al.. Risk factors for spontaneous abortion from a prevention perspective in rural China: a population-based follow-up study. J Matern Fetal Neonatal Med, 2021, 34(16): 2583-2591

[16] ZengLX, YanH, ChenZJ. Study on the current status and risk factors of spontaneous abortion of women at reproductive age in rural areas of Xianyang district, Shaanxi province. Zhonghua Liu Xing Bing Xue Za Zhi (Chinese), 2007, 28(1): 19-23

[17] SuY, XieX, ZhouY, et al.. Association of induced abortion with hypertensive disorders of pregnancy risk among nulliparous women in China: a prospective cohort study. Sci Rep, 2020, 10(1): 5128

[18] WangC. Induced abortion patterns and determinants among married women in China: 1979 to 2010. Reprod Health Matters, 2014, 22(43): 159-168

[19] TangL, WuS, LiuD, et al.. Repeat Induced Abortion among Chinese Women Seeking Abortion: Two Cross Sectional Studies. Int J Environ Res Public Health, 2021, 18(9): 4446

[20] WangX, WuJ, LiY, et al.. Changes in the Prevalence of Induced Abortion in the Floating Population in Major Cities of China 2007–2014. Int J Environ Res Public Health, 2019, 16(18): 3305

[21] ZhouZ, ZhengD, WuH, et al.. Epidemiology of infertility in China: a population-based study. Bjog, 2018, 125(4): 432-441

[22] HeY, ZhengD, ShangW, et al.. Prevalence of oligomenorrhea among women of childbearing age in China: A large community-based study. Womens Health (Lond), 2020, 16: 1745506520928617

[23] LiangS, ChenY, WangQ, et al.. Prevalence and associated factors of infertility among 20–49 year old women in Henan Province, China. Reprod Health, 2021, 18(1): 254

[24] HonigbergMC, ZekavatSM, AragamK, et al.. Association of Premature Natural and Surgical Menopause With Incident Cardiovascular Disease. Jama, 2019, 322(24): 2411-2421

[25] HonigbergMC, PatelAP, LahmT, et al.. Association of premature menopause with incident pulmonary hypertension: A cohort study. PloS One, 2021, 16(3): e0247398

[26] ShifrenJL, GassML. The North American Menopause Society recommendations for clinical care of midlife women. Menopause, 2014, 21(10): 1038-1062

[27] ShiboskiCH, ShiboskiSC, SerorR, et al.. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Ann Rheum Dis, 2017, 76(1): 9-16

[28] HarbuzMS, Chover-GonzalezAJ, JessopDS. Hypothalamo-pituitary-adrenal axis and chronic immune activation. Ann N Y Acad Sci, 2003, 992: 99-106

[29] LaBarberaAR, MillerMM, OberC, et al.. Autoimmune etiology in premature ovarian failure. Am J Reprod Immunol Microbiol, 1988, 16(3): 115-122

[30] MadhusudanD, RajuA, VijayaN. Correlation of Maternal Autoantibodies with Fetal Congenital Heart Block. J Obstet Gynaecol India, 2016, 66(Suppl 1): 112-116

[31] AnamiA, FukushimaK, TakasakiY, et al.. The predictive value of anti-SS-A antibodies titration in pregnant women with fetal congenital heart block. Mod Rheumatol, 2013, 23(4): 653-658

[32] AugustoKL, BonfaE, PereiraRM, et al.. Metabolic syndrome in Sjögren’s syndrome patients: a relevant concern for clinical monitoring. Clin Rheumatol, 2016, 35(3): 639-647

[33] KirshenbaumM, OrvietoR. Premature ovarian insufficiency (POI) and autoimmunity-an update appraisal. J Assist Reprod Genet, 2019, 36(11): 2207-2215

[34] StraubRH. The complex role of estrogens in inflammation. Endocr Rev, 2007, 28(5): 521-574

[35] Al-LamiRA, UrbanRJ, VolpiE, et al.. Sex Hormones and Novel Corona Virus Infectious Disease (COVID-19). Mayo Clin Proc, 2020, 95(8): 1710-1714

[36] HonmaN, HosoiT, AraiT, et al.. Estrogen and cancers of the colorectum, breast, and lung in postmenopausal women. Pathol Int, 2015, 65(9): 451-459

[37] Hsu LH, Chu NM, Kao SH. Estrogen, Estrogen Receptor and Lung Cancer. Int J Mol Sci, 2017,18(8)

[38] SprattDI, BuchsbaumRJ. COVID-19 and Hypercoagulability: Potential Impact on Management with Oral Contraceptives, Estrogen Therapy and Pregnancy. Endocrinology, 2020, 161(12): bqaa121

RIGHTS & PERMISSIONS

Huazhong University of Science and Technology